Exelixis, Inc.
EXEL
$54.55
$0.470.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.44B | 2.38B | 2.32B | 2.29B | 2.23B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.44B | 2.38B | 2.32B | 2.29B | 2.23B |
| Cost of Revenue | 85.67M | 84.48M | 83.70M | 77.18M | 75.94M |
| Gross Profit | 2.35B | 2.29B | 2.24B | 2.21B | 2.15B |
| SG&A Expenses | 533.92M | 521.15M | 518.73M | 530.03M | 518.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.44B | 1.42B | 1.43B | 1.47B | 1.48B |
| Operating Income | 992.02M | 957.18M | 892.70M | 820.25M | 751.74M |
| Income Before Tax | 1.04B | 1.00B | 941.21M | 873.29M | 775.63M |
| Income Tax Expenses | 174.84M | 169.78M | 158.64M | 195.39M | 173.34M |
| Earnings from Continuing Operations | 860.62 | 833.42 | 782.57 | 677.90 | 602.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 860.62M | 833.42M | 782.57M | 677.90M | 602.30M |
| EBIT | 992.02M | 957.18M | 892.70M | 820.25M | 751.74M |
| EBITDA | 1.02B | 985.84M | 921.76M | 850.00M | 781.52M |
| EPS Basic | 3.30 | 3.13 | 2.89 | 2.46 | 2.16 |
| Normalized Basic EPS | 2.53 | 2.40 | 2.22 | 2.03 | 1.85 |
| EPS Diluted | 3.18 | 3.01 | 2.77 | 2.37 | 2.08 |
| Normalized Diluted EPS | 2.44 | 2.32 | 2.14 | 1.96 | 1.79 |
| Average Basic Shares Outstanding | 1.04B | 1.07B | 1.09B | 1.10B | 1.12B |
| Average Diluted Shares Outstanding | 1.08B | 1.11B | 1.13B | 1.14B | 1.16B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |